X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Natco Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Natco Pharma Quarterly Results   (NTPH)

Here are the latest quarterly results of Natco Pharma. For more details, see the Natco Pharma financial fact sheet and Natco Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Natco Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,7905,7784,4534,2675,6227,6785,3865,435 
Other income Rs m61-63455114201359400 
Turnover Rs m6,8515,7724,4874,3225,7367,8795,7455,835 
Expenses Rs m4,1883,3673,0863,0482,7573,8453,2103,230 
Gross profit Rs m2,6042,4141,3671,2192,8653,8332,1762,205 
Depreciation Rs m137135150160172180184202 
Interest Rs m4664394243302850 
Profit before tax Rs m2,4822,2091,2121,0722,7643,8242,3232,353 
Tax Rs m531442275228590827512537 
Profit after tax Rs m1,9511,7679378442,1742,9971,8111,816 
Gross profit margin %38.441.830.728.651.049.940.440.6 
Effective tax rate %21.420.022.721.321.321.622.022.8 
Net profit margin %28.730.621.019.838.739.033.633.4 
Diluted EPS Rs 11.7 10.6 5.6 5.1 13.1 18.0 10.9 10.9  
Diluted EPS (TTM) Rs 22.2 29.2 32.0 33.1 34.4 41.8 47.1 53.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Natco Pharma 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ELDER PHARMA  DISHMAN PHARMA  ALEMBIC LTD  INDOCO REMEDIES  DIVIS LABORATORIES  

Compare NATCO PHARMA With:   ELDER PHARMA  DISHMAN PHARMA  ALEMBIC LTD  INDOCO REMEDIES  DIVIS LABORATORIES  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Open on a Positive Note; Energy & Power Stocks Lead(09:30 am)

Asian stock markets are trading on a negative note today. The Shanghai Composite is down 0.1% while the Hang Seng is down 0.2%.

Views on news

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

Follow a Super Investor Like This to Multiply Your Wealth(The 5 Minute Wrapup)

Jan 4, 2019

Following a super investor can certainly help build a portfolio and create wealth in the long term.

15 Mistakes to Avoid to Make a Killing in the Markets(Profit Hunter)

Jan 3, 2019

Richa dissects the common mistakes investors make and how to avoid and even take advantage of them.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 16, 2019 11:07 AM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATCO PHARMA

NATCO PHARMA - TEVA PHARMA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS